Mortality due to Covid-19 in Brazil: sociodemographic profile of the first weeks
DOI:
https://doi.org/10.33448/rsd-v10i1.11588Keywords:
COVID-19; SARS-CoV-2; Mortality; Risk factors.Abstract
On February 26, 2020, the Ministry of Health confirmed the first case of death by Covid-19 in Brazil. This study aimed to identify mortality from the disease in Brazil in the first 6 weeks after confirmation of the first case of death and to outline the profile of these individuals. This is a retrospective, descriptive cross-sectional study, which used data from the daily bulletins of the Ministry of Health. All cases of deaths occurred in Brazil by Covid-19, from March 17 to April 26, 2020, were analyzed. Data from all states of the federation were included and characterized by sex, age, skin color and presence of associated comorbidity. Among the deaths, 72% were from people over 60 years old, although about 80% of those infected did not belong to this age group. Still, 60% were male, even with an average of only 51.4% of infected males. The frequency of deaths was significantly higher among white individuals compared to brown and black individuals (p <0.0001). The mortality rate was 6.92%, being higher among males, the elderly - especially among those who had associated morbidities - and those with white skin.
References
Caramelo, F., Ferreira, N., & Oliveiros, B. (2020). Estimation of risk factors for COVID-19 mortality-preliminary results. MedRxiv. https://doi.org/10.1101/2020.02.24.20027268
Centers for Disease Control and Prevention (CDC). (2020). Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)-United States, 2020. Morbidity and Mortality Weekly Report (MMWR), 69(12), 343-346. https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm
Imanpour, H., Rezaee, H., & Nouri-Vaskeh, M. (2020). Angiotensin 1-7: A novel strategy in COVID-19 Treatment. Advanced Pharmaceutical Bulletin, 10(4), 488–489.
Ministério da Saúde. (2016). Resolução nº 510/2016: Diário Oficial da União. https://bvsms.saude.gov.br/bvs/saudelegis/cns/2016/res0510_07_04_2016.html
Ministério da Saúde. (2019). Dados e números da prevalência do tabagismo, 2019: Ministério da Saúde. https://www.inca.gov.br/observatorio-da-politica-nacional-de-controle-do-tabaco/dados-e-numeros-prevalencia-tabagismo
Ministério da Saúde. (2020). COVID-19. Painel coronavírus: Ministério da Saúde. https://covid.saude.gov.br/
Moreira, R. S. (2020). COVID-19: unidades de terapia intensiva, ventiladores mecânicos e perfis de mortalidade latente associados à letalidade no Brasil. Cadernos de Saúde Pública, 36 (5), e00080020.
Remuzzi, A., & Remuzzi, G. (2020). COVID-19 and Italy: what next? The Lancet, 395 (10231), 1225-1228.
Organização Pan-Americana da Saúde (OPAS). (2020). Folha informativa COVID-19 –Escritório da OPAS e da OMS no Brasil. Brasília, DF: OPAS. https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&Itemid=875
Schmidt, M. I., Duncan, B. B., Hoffmann, J. F., Moura, L. D., Malta, D. C., & Carvalho, R. M. S. V. D. (2009). Prevalência de diabetes e hipertensão no Brasil baseada em inquérito de morbidade auto-referida, Brasil, 2006. Revista de Saúde Pública, 43, 74-82.
Sullivan, J. C., Rodriguez-Miguelez, P., Zimmerman, M. A., & Harris, R. A. (2015). Differences in angiotensin (1-7) between men and women. American Journal of Physiology Heart and Circulatory Physiology, 308(9), H1171-6.
Teixeira, C. M., Madruga, G. D. A. M., Medeiros, G. B. D. S., Leite, J. G. T. M., & Duarte, S. S. M. (2020). Análise comparativa das pandemias COVID-19 e H1N1. Brazilian Journal of Health Review, 3(2), 3591-3595.
World Health Organization (WHO). (2019). Coronavirus disease (COVID-19) pandemic. Geneve: WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
World Health Organization (WHO). (2020). Coronavirus disease 2019 (COVID-19) situation report. Geneva, Switzerland: WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Zheng, Y. Y., Ma, Y. T., Zhang, J. Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), 259-260.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054-1062.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Elias Ferreira Porto; Alessandro Leipnitz Domingues; Anselmo Cordeiro de Souza; Mônica Karla Vojta Miranda; Morenilza Bezerra da Conceição Froes; Sérgio Rosa Vieira Pasqualinoto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.